Biopharma stocks take a beating as economic turmoil takes its toll — but some players with coronavirus efforts underway are up
The Biogen coronavirus outbreak has left most of its staff working from home — and it’s been no help for its share price. The stock $BIIB is down $5.5% Monday morning, as biopharma in general takes a beating during a stretch of severe economic turmoil.
As of this morning Saudi Arabia has declared an all-out price war with Russia over oil prices, which is driving down futures and roiling the stock market even further as the US and Europe looks at the impact of a swooning economy trying to shed the impact of a pandemic.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.